$PKTX
ProtoKinetix, Inc.

2024 Q3 Form 10-Q Financial Statement

#000107997324001123 Filed on July 30, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $51.05K
YoY Change -29.13%
% of Gross Profit
Research & Development $21.00K $21.00K
YoY Change -1.39% -34.33%
% of Gross Profit
Depreciation & Amortization $13.02K
YoY Change 12.53%
% of Gross Profit
Operating Expenses $84.57K $85.08K
YoY Change 5.2% -26.39%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$85.08K
YoY Change -26.39%
Income Tax
% Of Pretax Income
Net Earnings -$84.57K -$85.08K
YoY Change 5.2% -26.39%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 365.0M shares 352.9M shares
Diluted Shares Outstanding 364.8M shares 354.0M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.200K
YoY Change -88.21%
Cash & Equivalents $5.690K $2.200K
Short-Term Investments
Other Short-Term Assets $1.050K
YoY Change 0.0%
Inventory
Prepaid Expenses $1.050K $1.050K
Receivables
Other Receivables
Total Short-Term Assets $6.740K $3.250K
YoY Change -49.87% -83.51%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $472.5K $470.3K
YoY Change 8.02% 5.14%
TOTAL ASSETS
Total Short-Term Assets $6.740K $3.250K
Total Long-Term Assets $472.5K $470.3K
Total Assets $479.3K $473.5K
YoY Change 6.3% 1.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $87.75K $58.77K
YoY Change 598.53% 343.19%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $87.75K $58.77K
YoY Change 598.53% 343.19%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $87.75K $58.77K
Total Long-Term Liabilities $0.00
Total Liabilities $58.77K
YoY Change 343.21%
SHAREHOLDERS EQUITY
Retained Earnings -$48.13M -$48.04M
YoY Change 0.78% 0.78%
Common Stock $1.961K $1.930K
YoY Change 8.28% 7.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $391.5K $414.8K
YoY Change
Total Liabilities & Shareholders Equity $479.3K $473.5K
YoY Change 6.3% 1.4%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$84.57K -$85.08K
YoY Change 5.2% -26.39%
Depreciation, Depletion And Amortization $13.02K
YoY Change 12.53%
Cash From Operating Activities -$80.85K
YoY Change -43.76%
INVESTING ACTIVITIES
Capital Expenditures $25.78K
YoY Change 32.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$25.78K
YoY Change 32.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 106.0K
YoY Change -39.43%
NET CHANGE
Cash From Operating Activities -80.85K
Cash From Investing Activities -25.78K
Cash From Financing Activities 106.0K
Net Change In Cash -630.0
YoY Change -105.38%
FREE CASH FLOW
Cash From Operating Activities -$80.85K
Capital Expenditures $25.78K
Free Cash Flow -$106.6K
YoY Change -34.7%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
dei Entity Address City Or Town
EntityAddressCityOrTown
Dalton
dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
44618
dei City Area Code
CityAreaCode
740
dei Local Phone Number
LocalPhoneNumber
434-5041
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
364980152 shares
CY2024Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
2200 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
20408 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1050 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1050 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
3250 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
21458 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
470275 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
459099 usd
CY2024Q2 us-gaap Assets
Assets
473525 usd
CY2023Q4 us-gaap Assets
Assets
480557 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
58767 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
44696 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
58767 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
44696 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000053
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000053
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
346213485 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
346213485 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
1930 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1850 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
48453889 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
48297969 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-48041061 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-47863958 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
414758 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
435861 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
473525 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
480557 usd
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
13023 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11563 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
24341 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
22266 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13210 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
35715 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27335 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
68477 usd
CY2024Q2 us-gaap Professional Fees
ProfessionalFees
37843 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
36318 usd
us-gaap Professional Fees
ProfessionalFees
67802 usd
us-gaap Professional Fees
ProfessionalFees
77211 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31981 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
57625 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
54661 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
85076 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-85076 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
353972460 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
353972460 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
335630151 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
335630151 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
350278870 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
350278870 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
328025179 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
328025179 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
435861 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
156000 usd
us-gaap Profit Loss
ProfitLoss
-177103 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
414758 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
393835 usd
CY2024Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
106000 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-85076 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
414758 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
421340 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
255000 usd
us-gaap Profit Loss
ProfitLoss
-222615 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
453725 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
394302 usd
CY2023Q2 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
175000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-115577 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
453725 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-177103 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-222615 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
24341 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
22266 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
14071 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-28275 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-138691 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-228624 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
35517 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
33271 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-35517 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-33271 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
156000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
255000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
156000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
255000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-18208 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6895 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20408 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25550 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2200 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18655 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2015 PKTX Payment To Acquire Intangible Assets
PaymentToAcquireIntangibleAssets
30000 usd
CY2015Q4 PKTX Additional Patent Applications
AdditionalPatentApplications
10000 usd
CY2015 PKTX Warrant Issued
WarrantIssued
6000000 shares
CY2015 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
25000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84B_eus-gaap--UseOfEstimates_z2juE7ugDfch" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><span style="text-decoration: underline"><span id="xdx_862_zpoGDZpmGFhd">Use of Estimates</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period.  Actual results could differ from those estimates.  The more significant accounting estimates inherent in the preparation of the Company’s financial statements include estimates as to valuation of equity related instruments issued, deferred income taxes, and the useful life and impairment of intangible assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1050 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1050 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
514220 usd
CY2023 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
71088 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
585308 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
35517 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
620825 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
77950 usd
CY2023 PKTX Amortization
Amortization
48259 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
126209 usd
PKTX Amortization
Amortization
24341 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
150550 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
459099 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
470275 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
24341 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
22266 usd
CY2015Q4 PKTX Additional Patent Applications
AdditionalPatentApplications
10000 usd
CY2015 PKTX Warrant Issued
WarrantIssued
6000000 shares
PKTX Payments Related To Intangible Assets
PaymentsRelatedToIntangibleAssets
35517 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
94290000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
94290000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000053
CY2024Q2 us-gaap Dividends Receivable
DividendsReceivable
0 usd
CY2023Q2 us-gaap Dividends Receivable
DividendsReceivable
0 usd
CY2024Q2 PKTX Due To Related Parties Currents
DueToRelatedPartiesCurrents
3500 usd
CY2023Q2 PKTX Due To Related Parties Currents
DueToRelatedPartiesCurrents
0 usd
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001079973-24-001123-index-headers.html Edgar Link pending
0001079973-24-001123-index.html Edgar Link pending
0001079973-24-001123.txt Edgar Link pending
0001079973-24-001123-xbrl.zip Edgar Link pending
ex31x1.htm Edgar Link pending
ex31x2.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pktx-20240630.xsd Edgar Link pending
pktx_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pktx-20240630_cal.xml Edgar Link unprocessable
pktx-20240630_def.xml Edgar Link unprocessable
pktx-20240630_lab.xml Edgar Link unprocessable
pktx-20240630_pre.xml Edgar Link unprocessable
pktx_10q_htm.xml Edgar Link completed
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending